Latest Insider Transactions at Zogenix, Inc. (ZGNX)
This section provides a real-time view of insider transactions for Zogenix, Inc. (ZGNX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ZOGENIX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ZOGENIX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,156
-100.0%
|
-
|
|
Mar 07
2022
|
Denelle J Waynick Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
584
-100.0%
|
-
|
|
Mar 07
2022
|
Stephen J Farr President & CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
92,806
-100.0%
|
-
|
|
Mar 07
2022
|
Cam L Garner Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
81,843
-100.0%
|
-
|
|
Mar 07
2022
|
Shawnte Mitchell EVP, GC & Secretary |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
605
-100.0%
|
-
|
|
Mar 07
2022
|
Bradley S. Galer EVP & Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
25,022
-100.0%
|
-
|
|
Mar 07
2022
|
Erle T Mast Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,027
-100.0%
|
-
|
|
Mar 07
2022
|
Gail M Farfel Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
16,606
-100.0%
|
-
|
|
Mar 07
2022
|
Renee P Tannenbaum Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
32,567
-100.0%
|
-
|
|
Mar 07
2022
|
Mark C Wiggins Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,500
-100.0%
|
-
|
|
Mar 07
2022
|
James B Breitmeyer Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,250
-100.0%
|
-
|
|
Mar 07
2022
|
Michael P Smith EVP, CFO & Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,016
-100.0%
|
-
|
|
Feb 01
2022
|
Erle T Mast Director |
SELL
Open market or private sale
|
Direct |
1,250
-29.23%
|
$32,500
$26.04 P/Share
|
|
Feb 01
2022
|
Erle T Mast Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+22.62%
|
$15,000
$12.0 P/Share
|
|
Jan 19
2022
|
Erle T Mast Director |
SELL
Open market or private sale
|
Direct |
15,000
-83.21%
|
$390,000
$26.09 P/Share
|
|
Jan 19
2022
|
Erle T Mast Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+28.02%
|
$195,000
$13.97 P/Share
|
|
Nov 29
2021
|
Renee P Tannenbaum Director |
SELL
Open market or private sale
|
Direct |
5,305
-14.01%
|
$58,355
$11.72 P/Share
|
|
Aug 10
2021
|
Cam L Garner Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+19.61%
|
$140,000
$14.83 P/Share
|
|
Jul 02
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,114
-6.45%
|
$18,938
$17.74 P/Share
|
|
Jul 02
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.86%
|
-
|
|
Jun 01
2021
|
Denelle J Waynick Director |
BUY
Open market or private purchase
|
Direct |
584
+50.0%
|
$9,928
$17.07 P/Share
|
|
Jun 01
2021
|
Renee P Tannenbaum Director |
BUY
Open market or private purchase
|
Direct |
5,000
+11.66%
|
$85,000
$17.05 P/Share
|
|
May 10
2021
|
Cam L Garner Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+32.61%
|
$285,000
$19.03 P/Share
|
|
Mar 15
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,347
-5.36%
|
$26,940
$20.7 P/Share
|
|
Mar 15
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,531
+15.28%
|
-
|
|
Mar 15
2021
|
Gail M Farfel Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,864
-4.36%
|
$37,280
$20.7 P/Share
|
|
Mar 15
2021
|
Gail M Farfel Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,156
+10.73%
|
-
|
|
Mar 15
2021
|
Stephen J Farr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,836
-2.18%
|
$116,720
$20.7 P/Share
|
|
Mar 15
2021
|
Stephen J Farr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,875
+5.94%
|
-
|
|
Mar 15
2021
|
Michael P Smith EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-9.47%
|
$36,120
$20.7 P/Share
|
|
Mar 15
2021
|
Michael P Smith EVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,218
+21.4%
|
-
|
|
Mar 15
2021
|
Bradley S. Galer EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,462
-2.32%
|
$29,240
$20.7 P/Share
|
|
Mar 15
2021
|
Bradley S. Galer EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,218
+7.64%
|
-
|
|
Nov 19
2020
|
Cam L Garner Director |
BUY
Open market or private purchase
|
Indirect |
8,000
+33.33%
|
$160,000
$20.13 P/Share
|
|
Nov 17
2020
|
Renee P Tannenbaum Director |
SELL
Open market or private sale
|
Direct |
15,000
-31.33%
|
$300,000
$20.74 P/Share
|
|
Aug 10
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.4%
|
$5,200,000
$52.0 P/Share
|
|
Oct 03
2017
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
300,000
+7.03%
|
$11,100,000
$37.5 P/Share
|
|
Sep 29
2017
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
222,055
+0.55%
|
$7,549,870
$34.89 P/Share
|